ArticleHematology, transfusion and cell therapy2023

Clinical outcome and incidence of inhibitor development in severe hemophilia patients receiving low-dose prophylaxis: a 3-year follow-up study in Senegal, West Africa.

Sokhna Aïssatou Touré et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.